A Randomized, Fully-blinded Parallel Groups Study of Catheter Materials Used for Clean Intermittent Catheterisation

November 10, 2021 updated by: Wellspect HealthCare

A Multi-centre, Double-blind, Randomized, Parallel Groups Study Comparing PVC and Polyolefin-based Elastomer (POBE) as Catheter Materials, Outcomes Will be Measured by Subject Perception.

The study is designed as a randomized, double-blind, parallel-group, multi centre study comparing perception and tolerability of investigational product and comparator. In the randomized part of the study the subjects will be given either LoFric Primo (POBE) or the comparator LoFric Primo (PVC) for use over 4 weeks. The hypothesis is that subject perception and satisfaction of POBE is equal to or better than for PVC.

Study Overview

Study Type

Interventional

Enrollment (Actual)

195

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, A-1090
        • Medical University of Vienna, Department of Urology
      • Greifswald, Germany, 17487
        • NRZ Greifswald
      • Mönchengladbach, Germany, 41063
        • Kliniken Maria Hilf GmbH, Zentrum für Kontinenz und Neuro-Urologie, Krankenhaus St. Franziskus
      • Tübingen, Germany, 72076
        • BG-Klinik Tübingen
      • Firenze, Italy, 50139
        • Ospedale Careggi, Unità Spinale
      • Torino, Italy
        • Primario U.O. Neuro-Urologia, Direttore Dipartimento delle Mielolesioni
      • Bergen op Zoom, Netherlands, 4624 VT
        • Ziekenhuis Lievensberg, Afdeling Urologie
      • Dordrecht, Netherlands, 3300 AK
        • Albert Schweitzer Ziekenhuis, locatie Dordwijk
      • Eindhoven, Netherlands, 5602 ZA
        • Catharina Ziekenhuis
      • Nijmegen, Netherlands, 6500 HB
        • Radboud Univesity Nijmegen Medical Centre
      • Göteborg, Sweden, 413 45
        • Verksamhet Urologi, Sahlgrenska Universitets sjukhuset
      • Sheffield, United Kingdom, S10 2JF
        • Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital
      • Stanmore, United Kingdom, HA7 4LP
        • Royal National Orthopaedic Hospital, Spinal Injuries Unit, Brockley Hill Stanmore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Provision of informed consent
  • Males and females aged 18 years and over
  • Experienced users of LoFric Primo with a minimum of one month of use
  • Practice CIC with LoFric Primo at least 3 times per day
  • Adults able to read, write and understand information given to them regarding the study

Exclusion Criteria:

  • Ongoing symptomatic UTI
  • Suspicions of possible poor compliance with CIC during the study period
  • Previous enrolment or randomisation of treatment in the present study
  • Pregnancy
  • Subjects not able to perform self-catheterisation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: LoFric Primo (POBE) single-use urinary catheter
LoFric Primo (POBE) single-use urinary catheter
ACTIVE_COMPARATOR: LoFric Primo (PVC) single-use urinary catheter
LoFric Primo (PVC) single-use urinary catheter

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject's Perception Regarding Handling of Test Catheter Before Insertion
Time Frame: At 4 weeks
Subject's perception regarding handling of test catheter before insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
At 4 weeks
Subject's Perception Regarding Handling of Test Catheter at Insertion
Time Frame: At 4 weeks
Subject's perception regarding handling of test catheter at insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
At 4 weeks
Subject's Perception Regarding Handling of Test Catheter at Withdrawal
Time Frame: At 4 weeks
Subject's perception regarding handling of test catheter at withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
At 4 weeks
Subject's Perception Regarding Handling of Test Catheter After Withdrawal
Time Frame: At 4 weeks
Subject's perception regarding handling of test catheter after withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
At 4 weeks
Subject's General Satisfaction With Test Catheter
Time Frame: At 4 weeks
Subject's general satisfaction with test catheter, measured by mean score on a scale from 1 (Very satisfied) to 5 (Absolutely not satified)
At 4 weeks
Subject's Sensation When Using Test Catheter
Time Frame: At 4 weeks
Subject's sensation when using test catheter, measured by mean score on a scale from 1 (Comfortable) to 6 (Severe pain)
At 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alfred J Witjes, Prof Dr, Radboud Univesity Nijmegen Medical Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2007

Primary Completion (ACTUAL)

March 1, 2008

Study Completion (ACTUAL)

March 1, 2008

Study Registration Dates

First Submitted

September 15, 2008

First Submitted That Met QC Criteria

September 15, 2008

First Posted (ESTIMATE)

September 16, 2008

Study Record Updates

Last Update Posted (ACTUAL)

November 11, 2021

Last Update Submitted That Met QC Criteria

November 10, 2021

Last Verified

September 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • YA-CLO-0002

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Catheterization

Clinical Trials on LoFric Primo (POBE) single-use urinary catheter

3
Subscribe